Coe Laboratories, Inc. – Trademark Portfolio
Entity Type: 98
Coe Laboratories, Inc. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include COE and OMNIFLEX. The owner is based in Chicago, IL.
Chicago, IL
Showing of trademarks Trademarks
Trademark Classifications
Coe Laboratories, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Coe Laboratories, Inc. have?
Coe Laboratories, Inc. has 14 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned, 9 cancelled.
What trademark classes does Coe Laboratories, Inc. file in?
Coe Laboratories, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Coe Laboratories, Inc.'s most well-known trademarks?
Coe Laboratories, Inc.'s registered trademark portfolio includes well-known marks such as COE and OMNIFLEX. These are among 2 currently registered trademarks in the portfolio.
What is Coe Laboratories, Inc.'s trademark registration success rate?
Coe Laboratories, Inc. has a 14% trademark registration rate, with 2 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.